monounsaturated fatty acid
Showing 1 - 25 of >10,000
PreDiabetes, Insulin Resistance, Overweight Trial in Boston (Palmitoleic acid, Placebo)
Recruiting
- PreDiabetes
- +3 more
- Palmitoleic acid
- Placebo
-
Boston, MassachusettsBrigham and Women's Hospital
Nov 1, 2022
Brain Health, Brain Function, Brain Development Trial in Winston-Salem (Fish Oil, Safflower Oil)
Terminated
- Brain Health
- +2 more
- Fish Oil
- Safflower Oil
-
Winston-Salem, North CarolinaWake Forest Health Sciences
Jun 2, 2021
Lipoprotein Metabolism, PCSK9, Proteomics Trial run by the NHLBI (control fish oil, LCMUFA-rich saury oil)
Completed
- Lipoprotein Metabolism
- +2 more
- control fish oil
- LCMUFA-rich saury oil
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 3, 2020
Autism Spectrum Disorder Trial in Dhaka (Omega 3 fatty acid, Placebo of Omega-3 fatty acid softgel capsule)
Recruiting
- Autism Spectrum Disorder
- Omega 3 fatty acid
- Placebo of Omega-3 fatty acid softgel capsule
-
Dhaka, BangladeshBSMMU
Nov 5, 2023
Metabolic Syndrome Trial in Quebec (Monounsaturated fatty acids diet, Saturated fatty acids diet)
Recruiting
- Metabolic Syndrome
- Monounsaturated fatty acids diet
- Saturated fatty acids diet
-
Quebec, CanadaInstitute of Nutrition and Functional Foods (INAF)
Aug 31, 2021
Skeletal Muscle Fatty Acid Metabolism Trial in Kingston (Fish oil)
Not yet recruiting
- Skeletal Muscle Fatty Acid Metabolism
- Fish oil
-
Kingston, Ontario, CanadaSchool of Kinesiology and Health Studies
Aug 1, 2023
Strength, Body Composition, Muscle Soreness Trial in Waco (Omega-3 fatty acid, Placebo)
Completed
- Strength
- +2 more
- Omega-3 fatty acid
- Placebo
-
Waco, TexasBaylor University
Jun 20, 2023
Type 2 Diabetes, Non Alcholic Fatty Liver Disease Trial (Bempedoic acid)
Not yet recruiting
- Type 2 Diabetes
- Non Alcholic Fatty Liver Disease
- Bempedoic acid
- (no location specified)
Sep 14, 2023
Metabolic Associated Fatty Liver Disease Trial in Mexico (LUDLEV®300 mg/46.2 mg, Placebo)
Recruiting
- Metabolic Associated Fatty Liver Disease
- LUDLEV®300 mg/46.2 mg
- Placebo
-
Mexico, Veracruz, MexicoAna Delfina Cano Contreras
Jun 12, 2023
Cholestatic Liver Disease Trial in Shanghai (Rich medium chain fatty acid milk powder group, Regular milk powder group)
Not yet recruiting
- Cholestatic Liver Disease
- Rich medium chain fatty acid milk powder group
- Regular milk powder group
-
Shanghai, Chinazhaoyang Gou
Jun 26, 2023
Long Chain Fatty Acid Oxidation Disorders
Not yet recruiting
- Long-chain Fatty Acid Oxidation Disorders \(LC-FAOD\)
- Intermittent cardiopulmonary exercise test
- +4 more
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam UMC, location AMC
Jun 21, 2023
Dyslipidemias, Fatty Acid; Metabolic Disorder Trial in Padova (dark chocolate, White chocolate)
Completed
- Dyslipidemias
- Fatty Acid; Metabolic Disorder
- dark chocolate
- White chocolate
-
Padova, ItalyUniversity of Padova
Oct 3, 2023
Fatty Acid Oxidation in Cerebral Metastases Using [18F]FPIA
Recruiting
- Cerebral Metastases
- PET/MRI
-
London, United KingdomImperial College Healthcare NHS Trust
Jan 9, 2023
Healthy Aging, Ageing Well Trial in Stavanger (AvailOm, Placebo)
Not yet recruiting
- Healthy Aging
- Ageing Well
- AvailOm
- Placebo
-
Stavanger, NorwayStavanger Universitetssjukehus
Nov 20, 2023
Obesity, Abdominal, Diabete Type 2 Trial in Québec (Nutritionnal intervention)
Not yet recruiting
- Obesity, Abdominal
- Diabete Type 2
- Nutritionnal intervention
-
Québec, Quebec, CanadaInstitut sur la nutrition et les aliments fonctionnels - INAF
Jun 15, 2023
HIV Trial in Barcelona (Control group , Experimental group 1 lauric acid, Experimental group 2 lauric acid)
Recruiting
- HIV Infections
- Control group placebo
- +2 more
-
Barcelona, SpainHospital Universitario Vall d´Hebron
Jan 13, 2023
Obesity Trial in Zeist (Fatty acid composition of a margarine (spread))
Completed
- Obesity
- Fatty acid composition of a margarine (spread)
-
Zeist, Utrecht, NetherlandsTNO Quality of Life
Dec 13, 2022
Long-Chain Fatty Acid Oxidation Disorders Online Disease
Terminated
- Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
- No Intervention
-
Pittsburgh, PennsylvaniaChildren's Hospital of Pittsburgh of UPMC
Nov 14, 2022
Dry Eye Syndromes, Celiac Disease Trial in Tuzla (Omega-3 Fatty ACids, Control)
Recruiting
- Dry Eye Syndromes
- Celiac Disease
- Omega-3 Fatty ACids
- Control
-
Tuzla, Bosnia and HerzegovinaPlava Medical Group
Apr 11, 2023
LDL Hyperlipoproteinemia, Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia, Triglyceride Storage Type I or II Disease
Not yet recruiting
- LDL Hyperlipoproteinemia
- +2 more
- omega-3 fatty acids
- Placebo
-
Novosibirsk, Novosibisk Region, Russian FederationCenter of New Medical Technologies
Nov 30, 2023
Human Plasma Fatty Acid Oscillations
Suspended
- Nocturnal Eating-Drinking Syndrome
- Healthy
-
Philadelphia, PennsylvaniaInstitute for Translational Medicine and Therapeutics (ITMAT), U
Dec 22, 2022
Absorption, Pharmacokinetics Trial in Esslingen (PL+ omega 3 fatty acids, FO EE fatty acids)
Active, not recruiting
- Absorption
- Pharmacokinetics
- PL+ omega 3 fatty acids
- FO EE fatty acids
-
Esslingen, GermanyBioTeSys GmbH
Jan 31, 2023
Nutrition, Healthy Trial (Milk Protein Isolate (MPI), Soy Protein Isolate (SPI))
Not yet recruiting
- Nutrition, Healthy
- Milk Protein Isolate (MPI)
- Soy Protein Isolate (SPI)
- (no location specified)
Apr 18, 2023
Dry Eye Trial in Vienna (Aspirin 500Mg Tab, Dr. Böhm® Omega 3 complex 870 mg)
Completed
- Dry Eye
- Aspirin 500Mg Tab
- Dr. Böhm® Omega 3 complex 870 mg
-
Vienna, AustriaMedical University of Vienna, Department of Clinical Pharmacolog
Mar 7, 2023
Parkinson Disease Trial in Ann Arbor (tributyrin)
Recruiting
- Parkinson Disease
-
Ann Arbor, MichiganUniversity of Michigan Health System Functional Neuroimaging, Co
Sep 13, 2022